drugset
drugset / Trial / NCT03802331

A Study to Test How Food Influences the Amount of BI 1323495 in the Blood of Healthy Men

NCT03802331 ↗

Phase 1 Completed 12 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

The main objective of this trial is to assess the effect of food on the pharmacokinetics of an oral tablet formulation of BI 1323495 by investigating the relative bioavailability following single dose administration under fed and fasted conditions.

Timeline

Start
2019-01-28
Primary completion
2019-03-03
Completion
2019-03-03

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 1323495 Unknown — Oral

Indications

No indication recorded.